Mandibular Advancement Device (MAD) Therapy Pathway to Patients

PRE-MARKET ENGAGEMENT

The University Hospitals of North Midlands wishes to hear from organisations willing to share information about the provision of who can deliver a full Mandibular Advancement Device (MAD) Therapy Pathway to patients referred by the healthcare professionals, to gauge the likely level of interest in this provision from the market.

This is not an invitation to tender, nor does it preclude or favour eligibility to participate in the formal procurement once it starts. It is a process solely to test the current market capacity, to scope the services, and inform the procurement process.
Details in this PIN are subject to being updated or changed in the final tender notice.